Uncovering Microbiome-Derived Therapeutic Targets to Treat Alzheimer’s Disease

Time: 11:30 am
day: Track A - Day 2


  • Investigating Alzheimer’s disease in the context of the microbiome: what do biopharma need to know?
  • Analyzing how microbial DNAs involvement in Alzheimer’s disease can be exploited as a treatment strategy against it
  •  Revealing how DNA of some species triggers protein misfolding and learning how this influences Alzheimer’s development and progression